International Society of Liquid Biopsy shared a post on LinkedIn:
“ISLB Research Highlight!
Cerebrospinal Fluid Liquid Biopsy in CNS Tumors.
Key Findings:
– CSF liquid biopsy detected metastatic tumors in 82% of suspected cases.
– Chromosomal abnormalities and mutations (e.g., EGFR, KRAS, PIK3CA) identified in CSF cfDNA.
– Therapy monitoring demonstrated feasibility with serial CSF sampling.
LBx offers a reliable tool for CNS tumor diagnosis and monitoring.”
Authors: Ahmad Charifa et al.